What are TG Therapeutics's profit margins?

TG Therapeutics (TGTX) runs a 83.1% gross margin and a 21.3% operating margin, with a 66.0% net margin.

Where do TG Therapeutics's ratios come from?

Every ratio is computed from TG Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

TG Therapeutics TGTX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	83.1%-0.6pp	83.7%-1.7pp	85.3%-1.6pp	87%-0.5pp	87.4%-0.9pp
Operating margin	21.3%+1.3pp	20%+0.7pp	19.3%—	——	——
Net margin	66%-6.6pp	72.6%-11.6pp	84.1%—	——	——
Returns
Return on equity	112.6%+9.8pp	102.8%-9.2pp	112%—	——	——
Return on invested capital	23.9%+1.8pp	22%+2.2pp	19.8%—	——	——
Efficiency
Asset turnover	0.6×-0.1×	0.8×+0.1×	0.7×-0.2×	0.8×+0.1×	0.8×0.0×
Liquidity
Current ratio	5.8×+1.7×	4.1×+0.3×	3.8×0.0×	3.9×-0.2×	4×-2.2×
Leverage
Debt-to-equity	1.3×+0.9×	0.4×0.0×	0.4×-0.5×	0.9×-0.2×	1.1×-0.1×
Net debt / EBITDA	2.1×+0.7×	1.4×-0.3×	1.7×—	——	——
Per Share
Book value per share	$3.64-9.3%	$4.01+6.4%	$3.77+122%	$1.70+16.6%	$1.46+5.1%
Valuation
Market capitalization	$5.3B+12.1%	$4.73B-17.4%	$5.73B-3.2%	$5.92B-4.4%	$6.19B+32.2%
Price / earnings	11.5×+0.9×	10.6×-2.2×	12.8×—	——	——
Price / sales	7.6×-0.1×	7.7×-3.1×	10.8×-2.3×	13×-3.0×	16×+1.8×
Price / book	9.1×+1.8×	7.3×-2.1×	9.4×-12.0×	21.4×-4.7×	26.1×+5.0×
EV / EBITDA	37.5×-2.2×	39.8×-17.7×	57.5×—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about TG Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are TG Therapeutics's profit margins?: TG Therapeutics (TGTX) runs a 83.1% gross margin and a 21.3% operating margin, with a 66.0% net margin.
Where do TG Therapeutics's ratios come from?: Every ratio is computed from TG Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.